Takeda strengthens Berlin site as future German headquarters
The Constance site will be closed by the end of 2028
Advertisement
Takeda has announced that it will relocate the headquarters of Takeda GmbH, its Group company in Germany, from Constance to Berlin by the end of 2028. Berlin is already responsible for key sales activities in Germany. With the decision to also locate Takeda GmbH in Berlin, Takeda is strengthening its presence in the capital and will focus its activities on three locations in the future: Berlin, Oranienburg and Singen. The state-of-the-art production sites in Singen and Oranienburg will remain pillars of the organization and underline the importance of Germany as a key industrial location for Takeda.
"The move of the company headquarters to Berlin is a commitment to Germany, Takeda's fourth largest country," explained Dr. Ingeborg R. Borgheim, Managing Director of Takeda in Germany. "We are strengthening our presence in Berlin in addition to our two global production sites in Germany, which we operate in Singen (Baden-Württemberg) and Oranienburg (Brandenburg)."
The relocation of the German headquarters should be completed by the end of 2028. The Constance site, which for historical reasons was the headquarters of Takeda GmbH and the headquarters of Takeda Germany, will be closed by the end of 2028. The approximately 60 employees at the Constance site have been informed of the plans.
"We are aware that this is a significant change for our employees in Constance," said Michael Hartmann, Managing Director Human Resources and Labor Director of Takeda in Germany. "With today's announcement, we are informing our employees transparently and in good time. We are currently in talks with the works council."
With 2,300 employees in Germany, two global production sites and the future German headquarters in Berlin, Takeda is sending a clear signal in favor of Germany as a business location.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of current news. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
Other news from the department business & finance
Most read news
More news from our other portals
Last viewed contents
QIAGEN acquires bioinformatics company - Expanding clinical bioinformatics capabilities in molecular oncology
Remdesivir disrupts COVID-19 virus better than other similar drugs - How the COVID-19 drug remdesivir works at the molecular level
Scientists identify 160 new drugs that could be repurposed against COVID-19 - Forty of these drugs have already entered clinical trials
Transparency for clinical trials - Transparency of study results in a public dashboard
Bertelsmann Investments acquires stake in AI-powered Israeli healthcare startup QuantHealth - AI-supported start-up company for clinical trial planning
When eating is a burden - Study identifies new group of people affected by little-known eating disorder
The evolution of cancer cells decoded - "Our vision is a new type of early cancer detection"
New Label-Free Imaging Tracks Cancer Treatment in Single Cells - One Tool, Many Applications
Tumor cells target metastases as they die - A new drug can eliminate cancer cells while training the immune system to destroy such cells throughout the body
Transforming personalized medicine with AI-driven CAR-T manufacturing - Automated CAR-T cell production platform is ready for production
Edible, biodegradable fibers made from milk protein, cellulose - Sustainable food packaging, wound dressings, cosmetics, filtration and more are all areas in which work is showing promise
